These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


645 related items for PubMed ID: 26849891

  • 1. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.
    Kim HL, Kim D, Jang EJ, Lee MY, Song HJ, Park SY, Cho SK, Sung YK, Choi CB, Won S, Bang SY, Cha HS, Choe JY, Chung WT, Hong SJ, Jun JB, Kim J, Kim SK, Kim TH, Kim TJ, Koh E, Lee H, Lee HS, Lee J, Lee SS, Lee SW, Park SH, Shim SC, Yoo DH, Yoon BY, Bae SC, Lee EK.
    Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891
    [Abstract] [Full Text] [Related]

  • 2. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.
    Wallman JK, Eriksson JK, Nilsson JÅ, Olofsson T, Kristensen LE, Neovius M, Geborek P.
    J Rheumatol; 2016 Jul; 43(7):1292-9. PubMed ID: 27252420
    [Abstract] [Full Text] [Related]

  • 3. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
    Yoshii I, Chijiwa T, Sawada N.
    Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
    [Abstract] [Full Text] [Related]

  • 4. Hospital Anxiety and Depression Scale Score Is an Independent Factor Associated With the EuroQoL 5-Dimensional Descriptive System in Patients With Rheumatoid Arthritis.
    Hattori Y, Katayama M, Kida D, Kaneko A.
    J Clin Rheumatol; 2018 Sep; 24(6):308-312. PubMed ID: 29742541
    [Abstract] [Full Text] [Related]

  • 5. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.
    Carreño A, Fernández I, Badia X, Varela C, Roset M.
    Value Health; 2011 Jan; 14(1):192-200. PubMed ID: 21211502
    [Abstract] [Full Text] [Related]

  • 6. Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.
    Hoshi D, Tanaka E, Igarashi A, Inoue E, Kobayashi A, Sugimoto N, Shidara K, Sato E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Tsutani K, Yamanaka H.
    Mod Rheumatol; 2016 Jan; 26(1):40-5. PubMed ID: 26052801
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH, Cheung PWH, Samartzis D, Luk KD, Cheung KMC, Lam CLK, Cheung JPY.
    PLoS One; 2017 Jan; 12(4):e0175847. PubMed ID: 28414745
    [Abstract] [Full Text] [Related]

  • 10. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.
    Clin Exp Rheumatol; 2011 Jan; 29(4):661-71. PubMed ID: 21813061
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A, Green C, Telford C, Zajicek J, Wright D.
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [Abstract] [Full Text] [Related]

  • 15. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S, Kristiansen IS, Kvien TK.
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M.
    Pharmacoeconomics; 2010 Oct; 28(6):477-87. PubMed ID: 20465316
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.